CardiaTec is applying artificial intelligence on large-scale human multi-omics data to develop the next generation of cardiovascular disease drug targets.

Laidlaw Scholars Ventures

O2h Ventures

APEX Ventures

Crista Galli Ventures

University of Cambridge Enterprise

CardiaTec Biosciences

🌟 Advisor Spotlight: Dr. Christopher Miller 🌟

We are thrilled to introduce Dr. Christopher Miller, a valued member of our Scientific Advisory Board. Chris brings a distinguished career spanning 30 years in applied genomics, functional genomics, and multi-omics, having contributed significantly at Bristol Myers Squibb, AbbVie, Pfizer, and GSK. Throughout his career, Chris has played a pivotal role in drug target identification, target validation, drug discovery, and development, translating results from human genetics into impactful drug discovery programs.

Welcome on board once again! 🚀

🌟 Spotlight 🌟

Thrilled to see our COO & Co-Founder, Thelma Zablocki, at the InspiringFifty Women In Tech Breakfast organised by EQL:HER & Founders Forum Group, alongside Meta. 🎉

#WomenInTech #Leadership #AIdrugdiscovery #EQLHER #FoundersForumGroup #Meta 

Exciting news! Our founders will be at the LSX Conference on November 13th. This is a chance to connect and explore CardiaTec Biosciences's ambitions and future prospects 🚀 

Link: https://lnkd.in/eE_QBbD 

Apache

jsDelivr

Cloudflare JS

CDN JS

Apache 2.4

GoDaddy SSL

Express

OpenSSL

Mapbox

Amazon London Region

Co-Founder & CEO

Raphael Peralta

Senior Cardiovascular Scientist

Agata Rumianek

Senior Machine Learning Engineer

WooChang Hwang

Europe, Middle East, and Africa (EMEA) Seed Stage Companies With Fewer Than 50 Employees (Top 10K)

Europe Companies (Top 10K)

Artificial Intelligence (AI) Seed Stage Companies With Fewer Than 50 Employees (Top 10K)

Life Science Companies With More Than 10 Employees

CardiaTec is a TechBio business that uses computational tools to unravel the biology underlying cardiovascular illness. CardiaTec uses massive and high-dimensional human omics data to better understand complicated disease biology and identify novel and differentiated therapies.

Montage Ventures

Seed Round - CardiaTec Biosciences

Pre Seed Round - CardiaTec Biosciences

Cambridge

Cambridgeshire

United Kingdom

Europe

Thelma Zablocki on LinkedIn:

CardiaTec captures $1.7m

Utilizes AI-driven multi-omics analysis to identify new cardiovascular disease drug targets by examining gene variation, methylation, expression, and their connections to proteomic and metabolomic functions.

Explores computationally enabled target-drug interactions to develop novel cardiovascular drugs, focusing on a biology-first approach and being modality agnostic.

Investigates patient stratification and biomarker identification to determine patient endotypes most compatible with new therapeutics, aiming to enhance patient outcomes in cardiovascular disease treatment.

Spain

Italy

United States

North America

Taiwan

Asia

Cardiatec is a medical technology company specializing in developing innovative solutions for cardiovascular health monitoring and management.

Cardiatec

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 22, 2024 7:44 AM	5659e3a3
crunchbase profile	general	Nov 22, 2024 9:04 AM	9f4e720d
li profile	general	Feb 6, 2024 10:28 AM	e5df21d6
translate crunchbase fundingrounds	general	Nov 22, 2024 1:54 PM	59cd82b0
peers	general	Feb 6, 2024 10:28 AM	6f11fba4
news basic	general
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

AI:CARDIATEC

Cardiatec